Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A phase I and pharmacokinetic study of BAY59: a novel taxane.
Oncology. 2004;67(2):123-9. doi: 10.1159/000080998.
Oncology. 2004.
PMID: 15539916
Clinical Trial.
Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance.
Vredenburg MR, Ojima I, Veith J, Pera P, Kee K, Cabral F, Sharma A, Kanter P, Greco WR, Bernacki RJ.
Vredenburg MR, et al.
J Natl Cancer Inst. 2001 Aug 15;93(16):1234-45. doi: 10.1093/jnci/93.16.1234.
J Natl Cancer Inst. 2001.
PMID: 11504769
Item in Clipboard
The 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells.
Brooks TA, O'Loughlin KL, Minderman H, Bundy BN, Ford LA, Vredenburg MR, Bernacki RJ, Priebe W, Baer MR.
Brooks TA, et al. Among authors: vredenburg mr.
Invest New Drugs. 2007 Apr;25(2):115-22. doi: 10.1007/s10637-006-9018-3. Epub 2006 Oct 28.
Invest New Drugs. 2007.
PMID: 17072745
Item in Clipboard
Cite
Cite